Key Points
- Axon President Joshua Isner sold 16,775 shares for approximately $9.64 million under a pre-arranged Rule 10b5-1 trading plan, reducing his direct ownership by 5.35% to 296,974 shares.
- AXON shares opened at $506.98 and were down 2.2%, while the company reported quarterly revenue of $904.39 million, up 35.3% year over year, and earnings of $1.88 per share—above analyst expectations.
- Analyst sentiment remains positive, with 13 Buy ratings and three Holds producing a “Moderate Buy” consensus and an average price target of $730.92; institutional investors own 79.08% of the stock.
Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) President Joshua Isner sold 16,775 shares of the firm's stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the transaction, the president directly owned 296,974 shares in the company, valued at approximately $170,590,774.82. This represents a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Joshua Isner also recently made the following trade(s):
- On Friday, June 5th, Joshua Isner sold 13,000 shares of Axon Enterprise stock. The shares were sold at an average price of $488.45, for a total transaction of $6,349,850.00.
Axon Enterprise Trading Down 2.2%
Shares of AXON stock opened at $506.98 on Thursday. The stock has a market cap of $41.19 billion, a P/E ratio of 210.37, a price-to-earnings-growth ratio of 8.41 and a beta of 1.40. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $792.16. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The stock has a 50 day simple moving average of $566.59 and a 200 day simple moving average of $485.27.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm had revenue of $904.39 million during the quarter, compared to analysts' expectations of $876.42 million. During the same period in the previous year, the firm earned $2.12 EPS. The company's quarterly revenue was up 35.3% compared to the same quarter last year. On average, research analysts predict that Axon Enterprise, Inc will post 2.04 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the company. Evergreen Capital Management LLC boosted its stake in shares of Axon Enterprise by 3.8% in the 2nd quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company's stock valued at $342,000 after purchasing an additional 15 shares during the last quarter. Synergy Financial Group LTD raised its stake in Axon Enterprise by 1.4% during the third quarter. Synergy Financial Group LTD now owns 1,388 shares of the biotechnology company's stock worth $996,000 after buying an additional 19 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in Axon Enterprise by 1.2% during the second quarter. Tower Research Capital LLC TRC now owns 1,631 shares of the biotechnology company's stock worth $1,350,000 after buying an additional 19 shares during the last quarter. Pure Financial Advisors LLC lifted its holdings in Axon Enterprise by 6.7% in the fourth quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company's stock valued at $207,000 after buying an additional 23 shares during the period. Finally, Astra Wealth Partners LLC boosted its position in Axon Enterprise by 7.1% during the fourth quarter. Astra Wealth Partners LLC now owns 375 shares of the biotechnology company's stock valued at $213,000 after acquiring an additional 25 shares during the last quarter. Institutional investors own 79.08% of the company's stock.
Analyst Ratings Changes
Several analysts recently weighed in on AXON shares. UBS Group upped their price objective on Axon Enterprise from $440.00 to $600.00 and gave the stock a "neutral" rating in a research report on Thursday, August 6th. Morgan Stanley boosted their target price on Axon Enterprise from $600.00 to $640.00 and gave the stock an "overweight" rating in a research note on Thursday, August 6th. TD Cowen reaffirmed a "buy" rating on shares of Axon Enterprise in a research note on Wednesday, July 22nd. Barclays raised their price objective on Axon Enterprise from $523.00 to $688.00 and gave the company an "overweight" rating in a report on Thursday, August 6th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an "overweight" rating in a report on Thursday, May 7th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $730.92.
Read Our Latest Report on Axon Enterprise
About Axon Enterprise
(
Get Free Report)
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
